Atara Biotherapeutics, Inc. (ATRA)
9.76
+0.23
(+2.41%)
USD |
NASDAQ |
Sep 04, 16:00
10.34
+0.58
(+5.94%)
After-Hours: 20:00
Atara Biotherapeutics Profit Margin (Quarterly) : -767.3% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -767.3% |
| March 31, 2026 | -803.3% |
| December 31, 2025 | -213.5% |
| September 30, 2025 | -124.6% |
| June 30, 2025 | 13.58% |
| March 31, 2025 | 38.73% |
| December 31, 2024 | -38.75% |
| September 30, 2024 | -54.51% |
| June 30, 2024 | -66.51% |
| March 31, 2024 | -116.1% |
| December 31, 2023 | -1.42K% |
| Date | Value |
|---|---|
| September 30, 2023 | -3.26K% |
| June 30, 2023 | -7.43K% |
| March 31, 2023 | -6.10K% |
| December 31, 2022 | -33.74K% |
| September 30, 2022 | -1.89K% |
| June 30, 2022 | 35.80% |
| March 31, 2022 | -1.20K% |
| December 31, 2021 | -1.24K% |
| September 30, 2021 | -1.58K% |
| June 30, 2021 | -2.17K% |
| March 31, 2021 | -2.21K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
| Vericel Corp. | 2.85% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -64.19% |
| Return on Invested Capital | -94.43% |
| Gross Profit Margin (Quarterly) | 69.68% |
| Operating Margin (Quarterly) | -627.5% |
| Return on Net Operating Assets | -180.1% |